- Current report filing (8-K)
March 23 2010 - 11:32AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO
SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of
earliest event reported)
March 23, 2010
HEALTHTRONICS, INC.
(Exact name of registrant as
specified in its charter)
|
|
|
|
|
Georgia
|
|
000-30406
|
|
58-2210668
|
|
|
|
|
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
9825 Spectrum Drive,
Building 3
Austin, Texas 78717
(Address of principal executive offices including Zip Code)
(512) 328-2892
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure.
James Whittenburg, President and Chief Executive Officer of HealthTronics, Inc. (the Company), intends to make a series of
investor presentations on March 23 and 24, 2010. A copy of the presentation materials to be used in the presentations is furnished
pursuant to Item 7.01 of Form 8-K and shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act
of 1934 or otherwise subject to the liabilities of that Section, unless the Company specifically incorporates it by reference in a
document filed under the Securities Act of 1933 or the Securities Exchange Act of 1934. By filing this report on Form 8-K and
furnishing this information, the Company makes no admission as to the materiality of any information in this report that the Company
chooses to disclose solely because of Regulation FD. These presentation materials may be used in presentations to investors or at
conferences from time to time in the future.
The Company undertakes no duty or obligation to publicly update or revise the information contained in this report, although
the Company may do so from time to time as management believes is warranted. Any such updating may be made through the filing of
other reports or documents with the SEC, through press releases or through other public disclosure.
Certain expectations and projections regarding the Companys future performance referenced in the presentation materials are
forward-looking statements. These expectations and projections are based on currently available competitive, financial, and economic
data and are subject to future events and uncertainties. Among the events and uncertainties that could adversely affect future
periods are: the risk that the operations of Endocare, Inc. will not be successfully integrated; the risk that the Companys expected
cost savings and other synergies from the acquisition of Endocare may not be fully realized, realized at all or take longer to
realize than anticipated; the Companys inability to establish or maintain relationships with physicians and hospitals; the impact of
healthcare regulatory developments and changes; the inability of healthcare providers to obtain reimbursement for use of the
Companys current or future products; competition or technological change that impacts the market for the Companys products;
difficulty in managing the Companys growth; and other factors described in the Companys periodic reports filed with the SEC. In
addition to the above cautionary statements, all forward-looking statements contained herein should be read in conjunction with the
Companys SEC filings, including the risk factors described therein, and other public announcements.
Item 9.01 Financial
Statements and Exhibits.
Exhibit
Number
|
|
Description
|
|
|
99.1
|
|
Presentation materials.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
HEALTHTRONICS, INC.
(Registrant)
|
|
|
|
|
Date: March 23, 2010
|
|
|
|
By:
|
|
/s/
Richard A. Rusk
|
|
|
|
|
|
|
|
|
|
|
|
|
Name:
Title:
|
|
Richard A. Rusk
Chief Financial Officer and Vice President
|
|
|
|
|
EXHIBIT INDEX
Exhibit
Number
|
|
Description
|
|
|
99.1
|
|
Presentation materials.
|
Htetf (MM) (NASDAQ:HTRN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Htetf (MM) (NASDAQ:HTRN)
Historical Stock Chart
From Jul 2023 to Jul 2024